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Abstract
Background: The metabolic syndrome has been described in children; however, a standard criterion has not been 
established for its diagnosis. Also, few studies have been conducted to specifically observe the possible existence of 
agreement among the existing diagnostic criteria. The purpose of the study is to evaluate agreement concerning 
prevalence rates of the metabolic syndrome diagnosed by six different criteria in overweight schoolchildren in the city 
of Botucatu - SP -Brazil.
Methods: This is a cross-sectional study on 128 overweight schoolchildren. Clinical examination included 
anthropometry, pubertal staging evaluation, and blood pressure. Triacylglycerol, glycemia, HDL-cholesterol, insulin 
levels, and HOMA-IR were determined. The Kappa index, the Mann-Whitney test and the chi-square test were used for 
statistical analysis.
Results: The prevalence of the metabolic syndrome varied from 10 to 16.5% according to different diagnostic criteria. 
Results were similar for boys and girls and pubertal stage. Great agreement was observed among the six different 
diagnostic criteria for the metabolic syndrome.
Conclusions: Different diagnostic criteria, when adopted for subjects with similar demographic characteristics, 
generate similar and compatible prevalence. Results suggest that it is possible to adopt any of the analyzed criteria, 
and the choice should be according to the components available for each situation.
Background
Insulin resistance was firstly described by Reaven (1988)
[1] as the concomitant presence of abdominal adiposity,
dyslipidemia, hypertension and insulin resistance or
type-2 diabetes mellitus, and it is regarded as the main
risk factor for cardiovascular diseases.
The term syndrome was firstly used to describe a set of
risk factors utilized by a group of researchers whose main
focus was diabetes mellitus [2]. Reaven (1988) [1]
described syndrome X as a cluster of factors such as
abdominal adiposity, dyslipidemia, hypertension and
insulin resistance, emphasizing the role played by the lat-
ter as a possible precursor factor for the other diseases.
That syndrome was called by other researchers as the
insulin resistance syndrome, concentrating the discussion
on diabetes mellitus and hyperinsulinemia as possible
causal factors and disregarding overweight [3,4]. Later,
the Adult Treatment Panel III -National Cholesterol Edu-
cation Program (ATPIII-NCEP) began to refer to that
syndrome as the metabolic syndrome, with the purpose
to use the term in the more global context and consider
other causal factors related with abdominal fat excess [5].
Several studies [6-8] have evaluated the prevalence of
the metabolic syndrome in children or the isolated pres-
ence of its components, despite the inexistence of a single
diagnostic criterion. Disagreement concerning the choice
for the best diagnostic criterion mainly results from the
difficulty in establishing cutoff points due to the absence
of clinical manifestations of cardiovascular diseases in
childhood [9]. There are doubts whether cutoff points
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must be absolute or expressed in percentiles considering
age, gender and pubertal stage due to rapid growth in
childhood and mainly in adolescence [10].
As regards the prevalence of the metabolic syndrome at
this age range, data disagree according to the region,
diagnostic criteria and cutoff points adopted. In a popula-
tion-based study, the prevalence of the metabolic syn-
drome in American adolescents was 4.2% for the general
sample and 28.7% among overweight individuals [8].
Cruz et al. (2004) [11] found a 30% rate for the metabolic
syndrome in obese children and adolescents by adopting
another similar criterion to that previously cited; how-
ever, that was achieved by fixing the cutoff points in per-
centiles according to age and gender.
In Spain [12], the prevalence of the metabolic syn-
drome was 18% among obese children and adolescents. It
was a similar result to that observed in a French study,
which found 15.9% [13]. Nevertheless, in the National
Chinese Study on Health and Nutrition with a represen-
tative sample of children and adolescents, prevalence was
1.5% in eutrophic, 18.3% in overweight and 38.1% in
obese subjects [14].
In Brazil, data concerning the metabolic syndrome in
childhood are available from regional studies. Those
including overweight children and adolescents observed
a prevalence rate for the metabolic syndrome from 4 to
42.4% [15-18]. The diagnostic criteria used in the studies
were those proposed by the National Cholesterol Educa-
tion Program (NCEP) [5] and WHO (1998) [19] with
adaptations for age and cutoff points.
Despite the large number of studies available on the
prevalence of the metabolic syndrome in the pediatric
population, few have been conducted to specifically
observe the possible existence of agreement among diag-
nostic criteria, and studies of this type only show its vari-
ation when different criteria are adopted [20,21].
This study aimed at analyzing agreement concerning
the prevalence of the metabolic syndrome as diagnosed
by six different criteria in overweight schoolchildren in
the city of Botucatu, São Paulo State - Brazil.
Methods
This is a cross-sectional study conducted in three pri-
mary schools (private, public and non-governmental) in
Botucatu/SP - Brazil from June to December 2007. The
schools were selected based on approval by their princi-
pals and from the city's Secretary of Education.
The study was approved by the Research Ethics Com-
mittee of the Botucatu School of Medicine - UNESP,
according to official letter number 579/2006, as well as by
that of the Faculty of Pharmaceutical Sciences - USP,
according to document number 78/2007. All persons
responsible for the schools and the schoolchildren signed
a free consent form designed in accordance with resolu-
tion no. 196/96 concerning "Studies involving human
beings, by the Health Council of the Ministry of Health".
Initially, anthropometric and blood pressure measure-
ments were performed on all 6-to-10-year-old schoolchil-
dren (670 children) enrolled in the three schools. Later,
those diagnosed as overweight (231 children), as defined
by a body mass index (BMI) equal to or higher than the
85th percentile, based on the reference curves developed
by the National Center for Health Statistics - Center for
Disease Control and Prevention (CDC, 2000) [22], were
selected.
The nutritional diagnosis of overweight (BMI equal to
or higher than the 85th percentile and lower than the 95th
percentile) and/or obesity (BMI equal to or higher than
the 95th percentile) according to age and gender (CDC,
2000) [22] and the performance of the biochemical tests
proposed were considered as criteria for inclusion in the
study. The overweight schoolchildren with a clinical his-
tory of other morbidities and undergoing medical treat-
ment and clinical-nutritional follow-up for body weight
reduction were excluded.
All the children with an overweight/obesity diagnosis
were contacted by telephone in order to participate in the
study . Sample size estimation was based on the preva-
lence of overweight and obesity (18%) of this sample by
adopting a 7% margin of error. Therefore, the minimum
number of subjects was 115 children.
Body weight was measured by an electronic scale (Fili-
zola®) to the nearest 0.1 kg while the schoolchildren were
barefoot and wearing light clothes. Height was deter-
mined by a portable Seca® stadiometer to the nearest
01.cm, according to norms proposed by the World Health
Organization (WHO, 1995) [23]. BMI (weight in kilo-
grams divided by the squared height in meters) was cal-
culated by using the measured height and weight and
converted to percentiles for age in months and gender by
using the Center for Disease Control and Prevention
(CDC, 2000) [22] growth charts and computer software
Epi-Info® version 3.2 (2004). Waist circumference (WC)
was measured midway between the rib cage and the
superior border of the iliac crest by using a millimetric
non-extensible and non-elastic measuring tape (Sanny®)
after complete expiration.
The triceps (TSF) and subscapular (SSSF) skinfold
thicknesses were measured three times to the nearest 1.0
mm on the right side of the body by Lange® Skinfold cali-
pers (Cambridge Scientific Industries, Inc, Cambridge,
MD), and the mean values were used in the analyses. The
triceps skinfold was then measured parallel to the long
axis of the arm midway between the acromion and the
olecranon, with the arm slightly flexed, and the subscapu-
lar skinfold was measured below the lower angle of the
left scapula at a diagonal in the natural cleavage of theRinaldi et al. Diabetology & Metabolic Syndrome 2010, 2:39
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skin. Fat mass was calculated from skinfold thickness
measurements by using age and gender-specific equa-
tions proposed by Slaughter et al. (1988) [24]. The refer-
ence values adopted for body fat percentage were
proposed by Lohman (1987) [25], and values equal to or
higher than 25% for girls and equal to or higher than 20%
for boys were classified as mildly high.
Blood pressure was measured by the auscultatory
method after the child had been sitting at rest for a mini-
mum period of 5 minutes, and the cuff involved 80% of
the right arm's circumference. The arm rested on a sup-
port surface at the level of the precordium. Three variable
cuff sizes were used according to the child's brachial cir-
cumference. Blood pressure was measured three times in
three different days only when the first measurement was
above 95th percentile according to gender, age and
height, based on T he F ourth Report on the Diagnosis,
Evaluation, and Treatment of High Blood Pressure in
Children and Adolescents [26].
Fasting glucose, HDL-cholesterol and triacylglycerol
concentrations were quantified by using a semi-auto-
matic spectrophotometer (Labquest®, Labtest Diagnóst-
ica) and commercial kits (Labtest Diagnóstica) by the
enzymatic colorimetry method. The serum aliquots were
stored at a temperature of -80°C for later insulin analysis
by the immunochemical luminescence method using
commercial kits (DPC Medlab) and an automated device
(Immulite 2000®; DPC Medlab). HOMA-IR (Homeostasis
Model Assessment-Insulin Resistance) was calculated
according to the formula: fast insulin (UI/L) x fast glyce-
mia (mmol/L)/22.5, as proposed by Levy et al (1998) [27].
Pubertal stage was assessed in all children by a pediatri-
cian using the 5-stage scale for breast development and
pubic hair in girls; testicular size and pubic hair in boys,
according to Tanner (1962) [28]. The children were there-
after categorized into 3 groups: prepubertal (Tanner stage
1), pubertal (Tanner stage 2-4) and postpubertal (Tanner
stage 5).
These criteria were selected because their components
could be easily obtained and because they presented cut-
off points that were already adapted to the pediatric age
range. For each selected criterion, the reference values
established by their respective authors (Table 1) were
respected. The metabolic syndrome diagnosis was estab-
lished, in all criteria, by the presence of three or more
altered components.
After of the evaluations, the children's parents received
the results (anthropometric assessment, biochemical
tests and blood pressure). All the children were given
nutritional advice, and those with a diagnosis for high
blood pressure were referred to the pediatric nephrology
outpatient unit of the Botucatu School of Medicine, Bra-
zil.
The data were processed in software SPSS version 12.0
(SPSS Inc., Chicago, IL, USA). Data normality was evalu-
ated by the Shapiro-Wilk Test. Descriptive statistics are
displayed as arithmetic means and standard deviation.
Comparison between genders for the anthropometric
and biochemical data was performed by the Mann-Whit-
ney Test. Agreement among the six different criteria was
evaluated by the Kappa Index, which expresses the con-
sistency or agreement of results when measurement or
examination is repeated in identical conditions. The
interpretation of results was based on the following inter-
vals: smaller than zero, poor; from 0.00 to 0.20, little;
from 0.21 to 0.40, reasonable; from 0.41 to 0.60, moder-
ate; from 0.61 to 0.80, substantial and from 0.80 to 1.00,
almost perfect [29]. The Wilcoxon test was used to com-
pare the number of altered components in each criterion.
The possible influence of gender, pubertal staging, nutri-
tional status diagnosis by BMI (overweight and obesity)
and body fat percent of the metabolic syndrome was
tested by the Chi-square or Fischer's exact test. P values
0.05 were considered statistically significant.
Results
After the schoolchildren's (N = 670) anthropometric
assessment, overweight prevalence was observed in 33%
of the sample (16.1% overweight and 17.7% obesity), with
a proportion of obese/overweight to eutrophic individu-
als of 1:3. Of the overweight schoolchildren participating
in the present study (n = 128), 44% (n = 56) showed over-
weight, and 56% (n = 72) showed obesity, with a propor-
tion of obese/overweight individuals of 1:1. Boys showed
greater alterations in BMI (percentile), mean glycemia
levels and systolic pressure (Table 2). As regards pubertal
stage, 67% of the schoolchildren were classified as prepu-
bertal, 33% pubertal and none as postpubertal (data not
shown).
The prevalence of the metabolic syndrome varied from
10 to 16.5%. The percent of altered components was
more frequent in obese children according to the criteria
proposed by Ferreira et al (2007) [15], Silva et al (2005)
[16], Monzavi et al (2006) [30] and Cook et al (2003) [8]
(p < 0.05) and in individuals with high body fat percents
according to the criteria proposed by Ferreira et al (2007)
[15], Silva et al (2005) [16], Monzavi et al (2006) [31] and
Cook et al (2003) [8]; however, there was no influence
from gender or pubertal staging (Figure 1).
Anthropometric indicators (BMI and WC), triacylglyc-
erols, HDL-C, HOMA-IR, blood pressure and glycemia
constituted the decreasing sequence of prevalences of
altered components in the criteria adopted (Table 3).
The percent of zero or one of the syndrome's altered
components was significantly higher among overweight
children while the percent of two or more altered compo-R
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Table 1: Description of the metabolic syndrome criteria and their respective cutoff points.
Metabolic syndromecriteria
Age group of children in the studies 7-11 years 10-19 years 6-11 years 8-12 years 8-16 years 12-19 years
Metabolic syndrome components Ferreira et al15 Silva et al16 Boney et at30 Braunschweig et al7 Monzavi et al31 Cook et al8
Anthropometric indicators* BMI≥95th percentile BMI≥97th percentile IMC≥85th percentile WC≥90th percentile BMI≥95th percentile WC≥90th percentil
Insulin resistance indicators** Glycemia>100 HOMA>2.5 Glycemia >110 Glycemia≥110 Glycemia≥100 Glycemia≥100
HDL-C (mg/dL) ≤38 ≤35 <5th percentile ≤40 ≤10th percentile ≤40
Triglycerides (mg/dL) ≥110 ≥130 >95th percentile ≥110 ≥90th percentile ≥110
SBP/DBP (mmHg) >95th percentile ≥95th percentile >95th percentile ≥90th percentile ≥90th percentile ≥90th percentile
*BMI = body mass index or WC = waist circumference **impaired fasting glucose/HOMA-IRRinaldi et al. Diabetology & Metabolic Syndrome 2010, 2:39
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nents was higher in obese children (p < 0.05) for all crite-
ria. No children showed altered fast glycemia according
to the criteria proposed by Boney et al (2005) [31] and
Braunschneig et al (2005) [7], and only one showed
abnormal values according to the criteria proposed by
Cook et al (2003) [8], Monzavi et al (2006) [30] and Fer-
reira et al (2007) [15].
For all criteria, the cutoff points for blood pressure,
HDL-C and triacylglycerols were similar, a fact that
explains the absence of significant difference between the
prevalence of alteration in these components according
to the six criteria analyzed. Based on this information, it
can be assumed that the differences in the prevalence of
the metabolic syndrome found among the different crite-
ria were mainly due to anthropometric indicators (BMI
or WC) and to the glucose metabolism (HOMA-IR or
fasting glycemia) (Table 3).
All the criteria agreed among each other, and the Kappa
indexes generated values classified as moderate to almost
perfect. Perfect agreement was observed among the crite-
ria proposed by Cook et al (2003) [8] vs. Braunschneig et
al (2005) [7] and Cook et al (2003) [8] vs. Ferreira et al
(2007) [15]. Such result can be explained by the fact that
the three criteria have been adapted from that proposed
by NCEP-ATPIII with different cutoff-point adaptations.
The criteria showing the least agreement among each
other were those proposed by Silva et al (2005) [16] vs.
Boney et al (2005) [31], with a Kappa index of 0.53, con-
sidered to be moderate agreement (Table 4).
In these subjects, the prevalence of the metabolic syn-
drome, according to different criteria, showed good
agreement. In the same group of subjects, the percent of
children diagnosed with the metabolic syndrome seems
to show little variance in function of the diagnostic crite-
rion adopted.
Discussion
Divergent metabolic-syndrome diagnoses at the pediatric
age range encouraged the development of this Brazilian
study, which is one of the first to evaluate its prevalence
agreement according to different diagnostic criteria. The
prevalence of the metabolic syndrome varied according
to the criteria adopted; however, moderate to perfect
agreement was observed among all criteria. Such criteria
[7,8,15,16,30,31] were selected because the components
used were easy to obtain and because they were applied
to a similar age range to that in this study, except for the
criterion proposed by Silva et al (2005) [16] and Cook et
al (2003) [8]. The latter was selected because recent liter-
ature reviews [32,33] have shown it to be the most fre-
Table 2: Anthropometric and biochemical characteristics of school children according to gender. Botucatu-SP, 2007.
Variables General Boys Girls
n = 128 n = 58 n = 70
Age (years) 8.1 ± 1.4 8.1 ± 1.4 8.1 ± 1.4
Height (m) 1.3 ± 0.1 1.3 ± 0.1 1.3 ± 0.1
Weight (kg) 41.3 ± 11.1 42.9 ± 12.3 40.0 ± 10.0
BMI (kg/m 2) 22.2 ± 3.2 22.6 ± 3.6 21.8 ± 2.7
BMI (percentile) 94.3 ± 4.3 95.3 ± 3.9a 93.4 ± 4.5b
WC (cm) 72.1 ± 9.8 74.0 ± 11.1a 70.6 ± 8.4b
TSF (mm) 20.3 ± 4.7 20.2 ± 4.8 20.4 ± 4.7
SSF (mm) 14.7 ± 5.8 14.6 ± 6.3 14.8 ± 5.3
%BF 28.9 ± 6.5 29.5 ± 7.5 28.4 ± 5.6
Glycemia (mg/dL) 83.7 ± 6.5 85.6 ± 5.9a 82.1 ± 6.6b
HDL-C (mg/dL) 47.8 ± 10.9 47.5 ± 9.7 48.0 ± 11.9
Insulin (μU/mL) 7.6 ± 5.6 7.0 ± 4.7 8.2 ± 6.2
HOMA-IR 1.6 ± 1.2 1.5 ± 1.0 1.6 ± 1.3
TG (mg/dL) 98.0 ± 51.4 99.7 ± 56.6 96.5 ± 47.0
SBP (mmHg) 98.9 ± 12.1 101.3 ± 13.6 96.9 ± 10.5
DBP (mmHg) 63.9 ± 8.4 64.9 ± 9.4 63.2 ± 7.5
Different letters indicate significant difference between genders (p < 0.05). BMI: body mass index; WC: waist circumference; TSF: triceps 
skinfold, SSF: subscapular skinfold, %BF: percentage body fat; HOMA-IR: Homeostasis Model Assessment-Insulin Resistance; TG: triglycerides; 
SBP: systolic blood pressure; DBP: diastolic blood pressure.Rinaldi et al. Diabetology & Metabolic Syndrome 2010, 2:39
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quently used criterion, regardless of age range. This is
certainly due to the fact that it is based on NCEP-ATPIII,
which is already well founded among adults. Most of the
articles available in the literature include adolescents or
children in late childhood [8,34-36]. The other criteria,
Silva et al (2005) [16], were selected because this study
included Brazilian adolescents.
Although the six diagnostic criteria used differed in
relation to the cutoff points for each component, there is
agreement with regard to including indicative parameters
for glycemic (fasting glycemia and HOMA-IR) and lipid
(triacylglycerols, HDL-C) abnormalities, one anthropo-
metric indicator (BMI or WC) and blood pressure. In this
s t u d y ,  i t  c a n  b e  o b s e rv e d  t h a t  t h e  c o m p o n e n t s  m o s t l y
contributing to prevalence variation in the metabolic syn-
drome were the inclusion of BMI or WC and the cutoff
point adopted for each of them as well as the choice for
glycemia or HOMA-IR. The other components use very
similar cutoff points. Such findings are in agreement with
the analysis by Brambilla et al (2007) [37] in a review
study showing different prevalences according to several
diagnostic criteria.
Figure 1 Prevalence of Metabolic Syndrome in the six diagnosis criteria according to gender (1A), sexual maturity (1B), and nutritional di-
agnosis by body mass index (1C) and body fat percentage (1D) in overweight children. Botucatu-SP, 2007. 1A -"black square" boys; "striped 
square" girls. 1B - "black square" prepubertal; "vertical line" pubertal. 1C - "black square" overweight; "horizontal line" obesity. 1D - "black square" normal 
%body fat; "checked square" elevated %body fat *p < 0.05.
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Table 3: Percentage of overweight children with altered metabolic syndrome components according to the six diagnosis 
criteria.
Diagnostic criteria
Altered metabolic syndrome 
components
Ferreira et al15 Silva et al16 Boney et al30 Braunschweig et al26 Monzavi et al31 Cook et al8
Adiposity indicators* 57.8 (74)*** 40.6 (52) 100.0 (128) 96.1 (123) 57.8 (74) 45.3 (58)
Insulin resistance indicators** 0.8 (1) 18.0 (23) 0.0 (0) 0.0 (0) 0.8 (1) 0.8 (1)
HDL-C 19.5 (25) 10.9 (14) 15.6 (20) 25.0 (32) 27.3 (35) 25.0 (32)
Triacylglycerol 26.8 (34) 16.4 (21) 29.7 (38) 26.6 (34) 30.5 (39) 26.6 (34)
SBP/DBP 11.8 (15) 12.5 (16) 11.8 (15) 14.8 (19) 14.8 (19) 14.8 (19)
Metabolic syndrome (%) 11.7 (15) 14.1 (18) 12.5 (16) 16.4 (21) 13.3 (17) 11.5 (15)
*BMI: body mass index/Waist circumference; **Fast glycemia/HOMA-IR; ***The number in all parenthesis represents the number of the 
children with altered metabolic syndrome components SBP/DBP (sistolic blood pressure or diastolic blood pressure).Rinaldi et al. Diabetology & Metabolic Syndrome 2010, 2:39
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As previously mentioned, the prevalence of the meta-
bolic syndrome in this study varied from 10 to 16.5%,
without differences between gender and pubertal staging,
as shown by other studies [7,11,18,20,30,35,38]. In this
investigation, the anthropometric variable was (WC or
BMI) the component with the highest percent of altera-
tion, a result which is in accordance with findings in other
studies [7,15,31].
As in other investigations, the present study also
showed the inexistence, among children at this age range,
of altered fasting glycemia. However, Golley et al (2006)
[21] point out the importance of analyzing fasting insu-
linemia, since the number of components of the meta-
bolic syndrome and their prevalence significantly
increased according to fasting insulinemia quartiles. Fer-
reira et al (2007) [15] reported that the higher HOMA-IR
tercile, the higher the risk factors for cardiovascular dis-
eases. A Brazilian study conducted on overweight prepu-
bertal children reported that a higher HOMS-IR than 2.5
showed good sensitivity and specificity to detect the met-
abolic syndrome [38].
Another aspect pointed out in some studies is the need
to adapt cutoff points according to age [20,21] Reinehr et
al (2007) [17] compared four diagnostic criteria for adults
and four for children/adolescents. When using the crite-
ria for adults, prevalence of the metabolic syndrome var-
ied from 6 to 14%, and among the criteria for children/
adolescents, it ranged from 18 to 39%. Golley et al (2006)
[21] showed that prevalence in 6-to-9-year-old children
according to two criteria for adults was 4%; however,
when the same criteria were adjusted according to that
age range, prevalence was 39%. The authors also point
out that the criteria including total cholesterol and trig-
lycerides and WC can explain most of the prevalence
variation in the metabolic syndrome.
The prevalence of the metabolic syndrome found in the
present study was similar to that in studies adopted as
reference for this investigation, except for the criterion by
Monzavi et al (2006) [30], which identified, in their popu-
lation, a prevalence of 49%. By that criterion, the preva-
lence of the metabolic syndrome found was 13%, and it
can be explained by the higher percent of children with
severe obesity in those authors' sample [30].
Agreement among the different criteria varied from
moderate to almost perfect. This result was expected
since the criteria proposed by Ferreira et al (2007) [15],
Braunschneig et al (2005) [7] and Cook et al (2003) [8] are
adapted from NCEP-ATPIII for adults; however, with dif-
ferent cutoff points. Seo et al (2008) [36], in a similar
study to the present investigation, found great agreement
(88.7%) among three distinct criteria for the metabolic
syndrome in adolescents.
In face of such disparities, the validity of the metabolic
syndrome diagnosis is presently being questioned. The
same author who firstly defined it has discussed its clini-
cal usefulness since the components are individually
treated [39]. Another point of discussion is whether the
components of the metabolic syndrome and the diagnosis
always have the same importance in assessing the risk for
developing cardiovascular diseases and whether the pres-
ence of two factors, and not three, would be sufficient to
identify a patient at risk [40].
The existing criteria do not seem to be ideal for various
reasons, such as: few longitudinal studies allowing for the
evaluation of the metabolic syndrome's components from
childhood to adulthood have been performed; family his-
tory concerning non-transmittable chronic diseases has
not yet been thoroughly investigated; few studies have
u s e d  f a s t  i n s u l i n e m i a  a s  a n  i n d i c a t o r  o f  t h e  g l u c o s e
metabolism or cutoff points according to pubertal stag-
ing; the inclusion of BMI as an anthropometric indicator
may overestimate the prevalence of the metabolic syn-
drome [40].
With such lack of agreement, some researchers have
chosen to use multivariate analysis, for children, with the
same components of the metabolic syndrome in adults
[10]. Eisenmann (2008) [41] proposed the estimation of a
score to diagnose the metabolic syndrome in children
including the following components: abdominal circum-
ference, triacylglycerols, HDL-C, blood pressure and glu-
cose intolerance. The great difference in this method is
the determination of the Z individual score for each child
Table 4: Agreement (Kappa index) among de metabolic 
syndrome prevalences according to six different diagnostic 
criteria.
Criteria Kappa Index p
Ferreira × Silva 0.67 < 0.001
Ferreira × Boney 0.73 < 0.001
Ferreira × Braunschweig 0.73 < 0.001
Ferreira × Monzavi 0.70 < 0.001
Ferreira × Cook 0.84* < 0.001
Silva × Boney 0.53 < 0.001
Silva × Braunschweig 0.61 < 0.001
Silva × Monzavi 0.64 < 0.001
Silva × Cook 0.69 < 0.001
Boney × Braunschweig 0.78 < 0.001
Boney × Monzavi 0.62 < 0.001
Boney × Cook 0.67 < 0.001
Braunschweig × Monzavi 0.63 < 0.001
Braunschweig × Cook 0.81* < 0.001
Monzavi × Cook 0.71 < 0.001
*perfect concordanceRinaldi et al. Diabetology & Metabolic Syndrome 2010, 2:39
http://www.dmsjournal.com/content/2/1/39
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without dichotomization of variables, thus providing it
with greater sensitivity. Recently, Eisenmann et al (2010)
[42] analyzed the validity of a continuous metabolic syn-
drome (cMetS) score derived from principal component
analysis based on the criteria by Cook et al (2003) [8].
cMetS score 3.72 was the optimal cutoff point with high
sensitivity (100%) and high specificity (94%), and it meant
the highest risk for the metabolic syndrome. However,
this method has a major limitation: it is sample-specific.
The main limitation in this study was the absence of a
control group consisting of eutrophic children, similarly
to other studies [15,18,30,35]. The studies including a
control group [11,20,30,34,37] showed no or low preva-
lence of the metabolic syndrome in eutrophic children.
The prevalences of the metabolic syndrome may have
been overestimated by the larger presence of obese chil-
dren (56%) in relation to those overweight. The use of
BMI as a component of the metabolic syndrome in the
different criteria may also overestimate its prevalence, a
condition described by another study [41].
The importance of this study in clinical practice for the
decision concerning the criterion to be used to diagnose
the syndrome and in the interpretation of results is note-
worthy. Although prevalences differed according to the
criterion adopted, agreement among the methods was
considered to be satisfactory. The results in the present
study can suggest that, in the same group of subjects,
children with metabolic abnormalities will be diagnosed
regardless of the diagnostic criteria selected.
It can also be speculated that the differences between
the cutoff points of the components, namely, blood pres-
sure, triacylglycerols, HDL-C and glycemia, are discreet.
As previously discussed, the difference between the crite-
ria is the choice for BMI or WC and fast glycemia or
HOMA-IR and which reference to use in order to estab-
lish the diagnosis of alteration. Agreement on the use of
the best anthropometric and glycidic indicator would
reduce prevalence divergences among studies.
Additionally, it is recommended that the glucose, insu-
lin and lipid levels of all children diagnosed with obesity
should be periodically observed, and if required, immedi-
ate intervention should be made before the metabolic
syndrome itself develops [21].
Besides of the metabolic syndrome diagnosis, other fac-
tors must be taken into account in cardiovascular risk
evaluation in childhood. Dyslipidemia in childhood does
not cause adverse health effects, such as acute myocardial
infarction, but its long-term effects have been investi-
gated. With the lack or scarcity of longitudinal studies on
dyslipidemia in childhood and cardiovascular diseases in
adulthood, studies make inferences, and a positive rela-
tion is found [43].
The latest recommendation from the American Associ-
ation of Pediatrics for dyslipidemia screening is the pres-
ence of a family history of premature cardiovascular
diseases or high total cholesterol concentrations, children
whose families have an unknown family history or who
have been diagnosed with overweight, obesity, high blood
pressure and diabetes mellitus [44]. Several studies have
shown a positive correlation between the presence of
family history for obesity, systemic high blood pressure,
dyslipidemia and type-2 diabetes mellitus and alteration
in the metabolic-syndrome components [45-48].
Low weight at birth also influences the development of
chronic diseases in adults, a phenomenon which is
referred to as programming [49]. Growth rates in the first
weeks of life are critical for later insulin resistance [50].
Fast weight gain soon after birth (0 to 6 months of life)
has shown a direct relation with the presence of the meta-
bolic syndrome components in adulthood [51].
The Non-alcoholic fatty liver disease is also related to
metabolic disorders, and it is thought to be a result of
obesity [52]. Kelishadi et al (2010) [53] have observed that
alteration in hepatic enzymes increased with body weight
gain, since it was twofold in overweight children and ado-
lescents and fourfold in obese children and adolescents as
compared to eutrophic individuals
Hence, an early diagnosis for overweight and the imple-
mentation of lifestyle changes are fundamental for pre-
venting, controlling and managing obesity and its
associated co-morbidities, such as the metabolic syn-
drome [54,55].
Conclusions
Although some authors mentioned the difficulty to com-
pare the prevalence of the metabolic syndrome, this study
showed that the six criteria are correlated with each
other. The prevalence of the metabolic syndrome varied
from 10 to 16.5% and anthropometric indicators (BMI
and WC) were the most altered components in all the cri-
teria adopted. Additionally, the prevalence of the meta-
bolic syndrome is higher in obese individuals as
compared to those overweight. Therefore, in the same
group of subjects, the prevalence of the metabolic syn-
drome is similar, regardless of the criterion selected.
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